Modified T cells offer kidney patient hope
Researchers developed a new treatment using genetically modified T cells, successfully reducing the immune response in patients with severe kidney failure allergies. This approach enabled them to safely undergo kidney transplants. The study showed a significant decrease in immune antibodies, and three patients were able to receive donor kidneys successfully. This opens new horizons for patients who face challenges in organ transplantation due to their immune system sensitivity.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)